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Abstract.  Thrombospondin (TSP) is a multidomain 
adhesive protein postulated to play an important role in 
the biological activity of the extracellular matrix.  To 
test this hypothesis, TSP-containing  fibrin and collagen 
matrices were evaluated for their capacity to support 
angiogenesis and cell growth from explants of rat 
aorta.  This serum-free model allowed us to study the 
angiogenic effect of TSP without the interference of at- 
tachment and growth factors present in serum.  TSP 
promoted dose-dependent growth of microvessels and 
fibroblast-like cells. The number of microvessels in 
TSP-containing  collagen and fibrin gels increased by 
136 and 94%,  respectively. The TSP effect was due in 
part to cell proliferation since a 97%  increase in 
[3H]thymidine incorporation by the aortic culture was 
observed. The effect was TSP-specific because TSP 
preparations  adsorbed with anti-TSP  antibody showed 
no activity. TSP did not promote angiogenesis directly 
since no TSP-dependent growth of isolated endothelial 
cells could be demonstrated.  Rather TSP directly 
stimulated the growth of aortic culture-derived 
myofibroblasts which in turn promoted microvessel 
formation when cocultured with the aortic explants. 
Angiogenesis was also stimulated by myofibroblast- 
conditioned medium.  Partial characterization  of the 
conditioned medium suggests that the angiogenic activ- 
ity is due to heparin-binding  protein(s) with molecular 
weight >30 kD.  These results indicate that matrix- 
bound TSP can indirectly promote microvessel forma- 
tion through growth-promoting effects on myofibro- 
blasts and that TSP may be an important  stimulator of 
angiogenesis and wound healing  in vivo. 
T 
HROMBOSPONDIN (TSP) 1 is a 450,000 dalton glyco- 
protein secreted by platelets in response to such physi- 
ological activators as thrombin and collagen (11). TSP 
comprises 3 % of the total platelet protein and 25 % of the 
total platelet secreted protein (43).  TSP is also synthesized 
and secreted by fibroblasts (9), smooth muscle cells (29), en- 
dothelial cells (15), and tumor cells (28, 30, 45). In most tis- 
sues examined thus far, TSP has been found in the extracellu- 
lar matrix (48).  The structure of TSP is conserved among 
various animal species since antibody against the human pro- 
tein cross-reacts with TSP from mouse, rat, pig, cow, sheep, 
dog, and turkey (36).  Like fibronectin,  TSP is composed of 
linear  polypeptide domains that specifically  interact  with a 
number of macromolecules such as heparin  (50), fibrinogen 
(43),  collagen  (19), and plasminogen  (4). 
Although  the precise biological role of TSP has yet to be 
fully established, it is generally accepted that TSP plays a 
major role in cell adhesion and cell-cell interactions.  For ex- 
ample,  TSP was found to promote the cell-substratum  adhe- 
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sion of a variety of cells, including platelets, melanoma cells, 
smooth muscle cells, endothelial  ceils, fibroblasts,  and epi- 
thelial  cells  (42).  In addition,  cells with very specialized 
functions such as keratinocytes  (44) and osteoblasts (31) at- 
tach to TSP. Finally, TSP promotes the irreversible aggrega- 
tion of platelets  (41). 
Recently, TSP has been implicated  in the mechanisms  of 
cellular proliferation.  For example,  it has been shown that 
(a)  TSP  potentiates  the  mitogenic  activity  of epidermal 
growth  factor  on  smooth muscle cells  (13),  (b)  platelet- 
derived-growth  factor induces smooth muscle cell TSP syn- 
thesis (12), (c) TSP stimulates  activation  of smooth muscle 
cell $6 kinase,  a protein kinase involved in the transition  of 
cells from the quiescent to the proliferative  state (37),  (d) 
anti-TSP antibodies  inhibit the growth in culture of smooth 
muscle cells (14, 15), and (e) TSP promotes the proliferation 
of human  fibroblasts  in culture (27).  In addition,  Murphy- 
Ullrich and  Hook (21) observed that  TSP inhibited  focal 
adhesion plaque formation by bovine aortic endothelial cells. 
These authors  suggested that TSP by destabilizing  cell ma- 
trix contacts facilitates mitosis and migration  during wound 
healing  and angiogenesis. 
Since a considerable amount of evidence as summarized 
above suggests that TSP promotes cellular proliferation,  it 
seemed reasonable to postulate that TSP incorporated in the 
extracellular  matrix might play a role in angiogenesis. To test 
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which allows study of angiogenesis without the confounding 
effects of serum factors (23) which like TSP might affect en- 
dothelial  cell behavior. We report here that matrix-bound 
TSP promotes rat aortic angiogenesis by stimulating growth 
of myofibroblasts. These ceils in turn stimulate microvessel 
formation by secreting soluble  heparin-binding angiogenic 
factor(s). 
Materials and Methods 
Materials 
All  reagents,  unless  specified otherwise,  were  purchased  from  Sigma 
Chem. Co. (St. Louis, MO). Tissue culture supplies were purchased from 
ICN Flow (Irvine, CA). MCDB  131  serum-free medium was purchased 
from Clonetics (San Diego, CA). Reagents for SDS-PAGE were obtained 
from Bio-Rad Labs.  (Richmond, CA). CN-activated Sepharose was pur- 
chased from Pharmaeia LKB Biotechnology Inc. (Piscataway,  N J). Intersti- 
tial collagen was prepared from rat tails according to Elsdale and Bard (6). 
Purified bovine basic fibroblast growth factor 0aFGF) was obtained from 
R&D Systems (Minneapolis, MN). 
TSP Purification 
TSP was purified from Ca  +2  ionophore A23187-activated  platelets (43). 
Purified TSP preparations contained no detectable levels of fibronectin, 
vitronectin, yon Willebrand factor, and less than 0.1% fibrinogen as previ- 
ously described (42). 
Angiogenesis Assay 
Rings of rat aortas were embedded in gels of fibrin or interstitial collagen 
and grown in serum-free MCDB 131 medium as previously described (23). 
TSP was added to the gel at a final concentration of 0.5-60 t~g,/rnl. Fibrin 
gels were prepared from a 3-mg/rnl solution of fibrinogen chromatographed 
on gelatin agarose to remove contaminating fibronectin, and lysine agarose 
to remove contaminating plasminogen (23). For fibrin gel cultures, epsilon 
aminocaproic  acid  (300  #g/ml)  was  added  to  the  medium  to  prevent 
fibrinolysis by the aortic explant. Gels of interstitial collagen were prepared 
from a l-mg/ml solution of rat tail collagen (23). The culture medium was 
changed every other day. Developing microvessels  were viewed and counted 
under an inverted light microscope according to published criteria (23). The 
length of the microvessels in the living cultures was measured by digitizing 
morphometry with a Bioquant IV image analysis system (24). 
Cell Culture 
Bovine aortic  endothelial cells  (BAE)  were  a  gift  from Denis  Gospo- 
darowicz, University of California, San Francisco. Rat aortic endothelial 
cells (RAE) were isolated from aortic rings by a nonenzymatic methokl (16) 
which has recently been modified in our laboratory to avoid contamination 
by fibroblasts and other nonendothelial cells (manuscript submitted for pub- 
lication). Briefly, aortic rings were cultured on a 35-mm plastic dish to ob- 
tain endothelial outgrowths. After mechanically removing any contaminat- 
ing nonendothelial spindle-shaped cells, the endothelial outgrowths were 
segregated in cloning rings, trypsinized, and subeultured in MCDB  131 
medium supplemented with 10%  FBS,  100 #/ml endothelial cell growth 
supplement (ECGS,  Collaborative Biomedical Products, Bedford, MA), 
and 200/~g/ml beparin. Both BAE cells and RAE cells immunostained for 
the endothelial marker factor VIII-related antigen (FVIII-RAg) and took up 
1-1'-dioctadecyl-3,3,3',3',-tetramethyl  indocarboxyanine perchlorate (DiI-Ac- 
LDL)  (Biomedical Technologies Inc.,  Stonghton,  MA).  Myofibroblasts 
were isolated nonenzymatically from the primary outgrowths of serum-free 
collagen gel cultures of rat aorta. Fragments of the aortic outgrowths were 
detached from the collagen gel with a 22 gauge needle and isolated under 
a dissecting microscope with a pulled glass pipette. They were then washed 
in medium, transferred to collagen-coated 18-ram dishes (Nunc, Interlab, 
Thousand Oaks, CA), and grown in MCDB 131 medium supplemented with 
10% FBS and 50/~g/ml gantamicin. As cultures were passed at a split ratio 
of 1:3, cells were characterized by immunohistochemistry and electron mi- 
croscopy. After repeat passages the cultures were composed almost exclu- 
sively of myofibroblasts. At this stage the myofibroblasts were cloned and 
further characterized immunohistochemically. BAE cells and  rat  aorta- 
derived myofibroblasts were cultured either in DMEM  containing  10% 
FBS, 100 U/ml penicillin, 100 tzg/ml streptomycin, and 50/~g/ml gentami- 
cin sulfate or in MCDB  131  medium supplemented with  10%  FBS and 
50 #g/ml gentamicin sulfate. 
Effect of  Myofibroblasts on Angiogenesis 
The effect of myofibroblasts on angiogenesis was studied either by incor- 
porating these cells in collagen gel cultures of rat aorta or by evaluating the 
stimulatory activity of their conditioned medium. For the coculture experi- 
ment, myofibroblasts were trypsinized, mixed with MCDB 131 containing 
10% FBS to neutralize the trypsin, centrifuged, and resuspended in serum- 
free medium. They were then washed extensively in serum-free medium to 
remove any residual serum, centrifuged, and resuspended in the collagen 
solution at increasing densities. Then, aortic rings were embedded in myo- 
fibroblast-containing collagen gels and cultured under serum-free condi- 
tions in MCDB 131 growth medium. For the conditioned medium experi- 
ment, serum-free MCDB 131 medium was conditioned by a 24-h incubation 
with exponentially growing subconfluent cultures of myofibroblasts. Colla- 
gen gel cultures of rat aorta were fed on alternate days with a  1:1 mixture 
of fresh MDCB 131 and conditioned medium. For partial characterization 
of myofibroblast angiogenic  activity,  conditioned medium  was  filtered 
through Amicon centricon concentrators (Amicon, Beverly,  MA) having 
molecular weight exclusion limits of I00,000,  30,000,  and  10,000. 
Filtrate fractions were assayed for their angiogenic activity in the rat aor- 
tic model as described above. Conditioned media was also applied to a 3-mi 
heparin-agarose column (Sigma Chem. Co.) equilibrated in Tris-buffered 
saline and the flow-through fraction assayed for angiogenic activity. 
Immunohistochemical Studies 
For immunohistochemistry, cell cultures were fixed in buffered formalin, 
rinsed in PBS, permeabilized in Triton X-100, blocked with nonimmune se- 
rum, reacted with anti-FVIII-RAg rabbit polyclonal antibody (1:250, Dako) 
or anti-alpha-smooth muscle actin mouse monoclonal antibody (1:2,000, 
Sigma Chem.  Co.),  rinsed in  PBS,  incubated with the appropriate bi- 
otinylated secondary antibody, rinsed in PBS, and reacted with the avidin- 
biotin-peroxidase complex (Vector,  Burlingame, CA). After washing with 
PBS, the cells were incubated with a diaminobenzidine solution containing 
H202,  rinsed in distilled water, and counterstained with Harris' hematoxy- 
lin. Collagen gel cultures of rat aorta were fixed in buffered formalin, em- 
bedded  in  paraffin,  and  serially  sectioned.  Histologic  sections  were 
deparaffinized and processed for immunohistochemical studies as described 
above. 
Transmission Electron Microscopy 
For ultrastructural studies, myofibroblast cultures and collagen cultures of 
rat aorta were fixed in 1% glutaraldehyde 4% formaldehyde in phosphate 
buffer, pH 7.4,  and embedded in EPON. Thin sections were.stained with 
uranyl acetate and lead citrate and examined with a Zeiss 10A transmission 
electron microscope. 
Cell Proliferation  Assays 
The effect of TSP on endothelial and myoflbroblast cell proliferationwas 
studied by the MTT assay for cell proliferation according to the procedure 
provided by Chemicon (Temecula, CA) and as reported (18). The principle 
of the assay is that MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-dipbenyl  tetrazo- 
lium bromide), a non-toxic pale yellow substrate, is taken up by living cells 
to yield a dark blue formazin product. The process requires active mito- 
chondria so dead cells will not form formazan. After 4 h of incorporation 
as little as 200 cells can be detected. The formazan color at 570 run is 
directly proportional to the number of cells and the assay can be performed 
in a microtiter dish and quantitated with a microplate reader. A calibration 
curve relating absorbance to cell number was determined for each cell line 
studied. For this assay, cells were maintained in MCDB 131 medium sup- 
plemented with 1% FBS for several days and then harvested with EDTA. 
Approximately  10,000-30,000  cells suspended in 300  /zl of serum-free 
MCDB 131 medium were plated per well of a 96 well microtiter plate and 
allowed to attach overnight. The medium was then changed to serum-free 
MCDB 131 medium containing no TSP or 30 ~g/ml TSP. Enough replicate 
wells were plated so that cells could be counted on days 0, 2, and 4 and 
that the average value of triplicate cultures could be determined per time 
point. The culture medium was changed every other day. 
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of endothelial  cells to respond  to exogenous  growth factors. For this experi- 
ment, RAE cells were cultured  on TSP-collagen-coated  microtiter  plates in 
serum-free MCDB 131 with or without bFGE For coating, each well was 
filled  with 50/~1  of MCDB 131 containing  50/~g/ml  TSP and 50 #g/ml colla- 
gen and kept at room temperature for 20-30 min. Then  the solution was 
aspirated and the plates were incubated  for 30 min at 37"C to induce  colla- 
gen fibrillogenesis  on the bottom of the wells. After rinsing with MCDB 
131 medium, each well received 10,000 RAE cells suspended in 100 ttl of 
serum-free MCDB 131 with or without 10 ng/ml  bFGF. In a separate ex- 
perimental group designed to test the effect of soluble TSP according to a 
previously published protocol (3), RAE cells were seeded on uncoated 
wells and fed with MCDB 131 medium supplemented  with I% FBS and 
10 ng/rnl bFGF with or without 50 #g/ml TSP. 
The effect of TSP on DNA synthesis  by endothelial  cells was studied by 
incubating  serum-free  cultures of BAE cells with 1 #Ci/ml [3H]thymidine 
for 5 h. Cultures  were prepared by seeding  4-well  Nunc culture  dishes with 
24,000 cells per well. After labeling, the cultures were rinsed with PBS, 
dissolved in tissue solubilizer,  added to a scintillation  fluid, and measured 
for radioactivity  in a scintillation  counter. The effect of TSP on growth of 
microvessels in matrix culture of rat aorta was monitored  by the uptake of 
[3Hlthymidine. DNA synthesis  by aortic outgrowths containing  either 30 
#g/ml BSA or increasing  concentrations  of TSP in the gel was determined 
by a 5-h pulse with 5 t~Ci/ml of [3H]thymidine. The cultures were then 
rinsed in PBS, dissolved  in tissue  solubilizer,  sonicated,  added to a scintilla- 
tion fluid, and counted for radioactivity. 
Western Immunoblotting 
Rabbit anti-TSP  antibody was characterized by Western immunoblotting 
using Pharmacia's  Phast gel electrophoresis system. Approximately  100 ng 
of TSP was separated under  reducing  conditions  on an 8-25 % polyacryl- 
amide gradient SDS gel. The gel-separated TSP was electrophoretically 
transferred onto nitrocellulose  paper and silver stained  or immunostained. 
For immunostaining,  the paper was blocked  with 1% BSA in PBS, contain- 
ing 0.05% Tween  20 (PBS-T) and treated with either 5 #g/ml of purified 
rabbit anti-TSP  or rabbit IgG for 1 h, washed with PBS-T, and developed 
according to the instructions  provided with the VECTASTAIN  ABC im- 
munoperoxidase system (Vector). 
Statistical  Analysis 
Data were analyzed  statistically  by Student's t test or analysis  of variance 
followed by Schefft's test of significance.  Statistical  significance  was set at 
p < 0.05. 
Results 
Effect of TSP on Angiogenesis 
The angiogenesis assay used in this study is based on the ob- 
servation that rings of rat aorta form microvessels when cul- 
tured in three-dimensional  gels of fibrin or collagen (22, 23). 
In this system microvessels develop in serum-free medium 
and do  not require addition of exogenous growth  factors 
(23). Since TSP binds fibrin (20) and collagen (19), the aor- 
tic ring model is ideal to evaluate the effect of matrix-bound 
TSP on angiogenesis. Addition of TSP to fibrin and collagen 
gel cultures of rat aorta stimulated angiogenesis. Angiogene- 
sis occurring in the presence of TSP was characteristically 
preceded by a marked increase in the outgrowth of fibroblast- 
like cells.  Fig.  1  shows  micrographs of aortic rings after 
8 d of growth in fibrin gels containing either no TSP or 50 
~g/ml TSP. Fig. 2 shows the same experiment performed in 
a collagen gel.  Both TSP- and non-TSP-containing  cultures 
developed  microvessels  that  proliferated,  branched,  and 
anastomosed with each other forming a network around the 
aortic  explant.  However,  TSP-treated cultures displayed a 
marked increase over control cultures in the number, length, 
and branching of the microvessels as well as in the number 
of fibroblast-like cells.  All microvessels were positive for 
FVIII-RAg as previously reported (23, 25). The fibroblast- 
like outgrowth  was  negative for  FVIII-RAg and included 
15-20%  alpha-smooth muscle actin-positive cells.  Alpha- 
smooth muscle actin positive cells were also seen around 
microvessels (25).  The expression of alpha-smooth muscle 
actin by these ceils was low during early stages of angiogene- 
sis and increased over time as the outgrowth matured and 
differentiated. 
The potentiating effect of TSP on angiogenesis was dose- 
dependent in both fibrin and collagen gels with little or no 
stimulation at concentrations at or below 5/~g/ml and maxi- 
mal stimulation at concentrations of 50-60/~g/ml. The time 
Figure 1. Serum-free cultures 
of rat aorta in fibrin gel (A and 
C)  and  fibrin  gel  sup- 
plemented with 50 #g/ml TSP 
(B and D).  Aortic  tings ex- 
posed to TSP (B and D) gave 
rise to a denser vascular out- 
growth  containing more  mi- 
crovessels  and fibroblast-like 
cells  than  aortic  tings  not 
treated with TSP. Arrows and 
arrowheads  indicate  micro- 
vessels  and  fibroblast-like 
cells, respectively. Magnifica- 
tions: A and B,  ×25;  C and 
D,  ×140. 
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growth of microvessels and fibroblast-like cells. The aortic explants are marked by asterisks. Arrowheads indicate microvessels. Magnifica- 
tion:  x45. 
course for TSP stimulation of  angiogenesis revealed that TSP 
began to promote microvessel formation on day 5 of culture. 
On day 9, a 94% increase in microvessel formation was ob- 
served in  TSP-containing fibrin gels  as  compared to  un- 
treated controls (Fig.  3).  In collagen gel cultures the TSP 
effect was even more pronounced with a  137% stimulation 
on day 9 (Fig. 3). Fibrin and TSP had an additive effect on 
angiogenesis,  and,  in  the  presence  of  both  molecules, 
microvessel formation continued to increase over time so 
that  after the  ninth  day  of culture  there  were  too  many 
microvessels and fibroblast-like cells to accurately quanti- 
tate.  In addition to promoting vascular proliferation, TSP 
stimulated  the  elongation of the  newly formed microves- 
sels.  The effect of TSP on microvascular length was dose- 
dependent and saturable (Fig. 4). Increased cellular prolifer- 
ation induced by TSP was further demonstrated by showing 
that TSP-treated cultures incorporated '~97 % more thymi- 
dine than controls when pulsed  with  [3H]thymidine after 
8 d of culture (Fig. 5). These experiments provide quantita- 
tive evidence that TSP promotes microvessel formation and 
proliferation of fibroblast-like cells in serum-free fibrin and 
collagen gel culture of rat aorta. 
Specificity of the Angiogenesis-promoting Activity 
of TSP 
The TSP used in these studies was electrophoretically pure 
as judged by silver-stained SDS-gels (Fig. 6). TSP, reduced 
by  beta-mercaptoethanol,  analyzed  as  a  major  band  of 
180,000 daltons. Previously, we demonstrated that our TSP 
preparations contained no detectable laminin,  fibronectin, 
vitronectin, or yon Willebrand  factor (42).  However, the 
possibility could not entirely be ruled out that our TSP con- 
tained trace amounts of growth factors that could contribute 
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Figure  3.  Effect  of  matrix- 
bound  TSP  on  the  growth 
curve of microvessels in fibrin 
(left) and collagen (right) gel 
cultures  of  rat  aorta.  TSP 
caused dose-dependent stimu- 
lation  of  angiogenesis.  50 
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the standard error of the mean 
(SEM). 
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Figure 5. Effect of TSP on DNA synthesis in fibrin gel cultures of 
rat  aorta.  8-d-old  cultures  were  incubated  with  5  /~Ci/ml 
[3H]thymidine for 5 h and measured for incorporation of radioac- 
tivity. 50 #g/ml TSP stimulated  DNA synthesis as compared to 
buffer control (C) and 50/~g/ml BSA (p < 0.01). Each data point 
represents the mean of triplicate  cultures  +  SEM. 
to its observed angiogenic activity. To address this question, 
TSP was adsorbed with a monospecific rabbit anti-TSP anti- 
body (Fig. 6) and tested for angiogenic activity. When 80% 
of the TSP was removed from a 50-#1  solution of TSP, the 
angiogenic effect was abolished (Fig. 7). These experiments 
suggest that TSP and not some contaminant promotes angio- 
genesis in our assay system. 
Effect of TSP on Endothelial Cell Proliferation 
To investigate the mechanism of the angiogenesis-promoting 
activity of TSP, the effect of TSP on the growth of endothelial 
cells in culture was determined. We initially found that 30 
#g/ml  of  TSP,  which  was  the  same  concentration  that 
promoted  angiogenesis  in  the  rat  aorta  model,  had  no 
stimulatory effect on the growth of BAE cells as measured 
by DNA synthesis (Fig. 8) and by cell counts (Fig. 9). Indeed 
previous studies have shown that soluble TSP inhibits the re- 
sponse of endothelial cells to bFGF (3). However, there are 
no reports on the effect of matrix-bound TSP on endothelial 
proliferation.  Since rat aortic angiogenesis is in part medi- 
ated by endogenous bFGF (46), we decided to test the effect 
of collagen-bound TSP on the proliferative response of RAE 
ceils to this growth factor. RAE cells grown on TSP-collagen 
substrate were unable to grow. However, they responded to 
bFGF  which  produced  a  threefold  increase in  endothelial 
Figure 6. Western blot analysis of anti-TSP antibody. TSP was ana- 
lyzed on an 8-25% polyacrylamide  gradient  SDS gel.  (Lane 1) 
silver-stained TSP; (lane 2) anti-TSP-stained TSP; (lane 3) nonim- 
mune IgG-stained TSP. 
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Figure 8. Effect of TSP on DNA synthesis by endothelial cells. Bo- 
vine aortic  endothelial  cells  (BAE) were  grown in  serum-free 
medium containing increasing concentrations of TSP and labeled 
with  1 #Ci/ml[3I-I]thymidine for 5 h.  TSP had  no stimulatory 
effect on endothelial proliferation. Each data point represents the 
mean of four replicate cultures  ±  SEM. 
cell number at day 4  (Fig.  10).  Conversely, soluble TSP 
added to the medium of RAE cells cultured on uncoated 
dishes abrogated the stimulatory effect of bFGF (data not 
shown) as previously reported by others (3). These results 
indicate that TSP does not stimulate angiogenesis directly by 
promoting the growth of endothelial cells. They also show 
that matrix-bound TSP, unlike soluble TSP, does not affect 
the proliferative response of endothelial cells to bFGE Since 
TSP does not stimulate endothelial cell proliferation directly, 
its angiogenic effect must be mediated by some other compo- 
nent in the system. 
Isolation and Characterization  of  Myofibroblasts from 
Rat Aorta Cultures 
The formation of microvessels from the aortic explants was 
always  preceded by  an  outgrowth  of fibroblast-like cells 
(Figs. 1 and 2). Immunohistochemical analysis showed that 
this outgrowth contained alpha-smooth muscle actin-posi- 
rive  cells.  Rat  aorta  culture-derived nonendothelial  cells 
were isolated,  subcultured, cloned, and characterized im- 
munohistochemicaily as myofibroblasts, based on a positive 
reaction for alpha-smooth muscle actin and negative FVIll- 
RAg  stain.  The  rat  aorta  culture-derived myofibroblasts 
were able to modulate the alpha-smooth muscle actin, ex- 
pressing this antigen in larger amounts in postconfluent cul- 
tures  (Fig.  11). UltrastructuraUy,  myofibroblasts  showed 
peripherally condensed myofilaments, abundant rough endo- 
plasmic  reticulum,  pinocytotic  vesicles,  and  were  sur- 
rounded by abundant extracellular matrix (Fig.  12). 
Effect of TSP on Proliferation of Rat Aorta 
Culture-derieed  Myofibroblasts 
To investigate~if the increased growth of fibroblast-like cells 
in collagen gel culture of rat aorta was due to TSP, we tested 
the effect of TSP on the proliferation of myofibroblasts. After 
4  d,  myofibroblasts grown in serum-free MCDB  131  me- 
dium containing 30 /~g/ml TSP approximately doubled in 
number whereas those grown in the absence of TSP showed 
no growth (Fig. 9). These results indicate that TSP has a di- 
rect proliferative effect on rat aorta-derived myofibroblasts. 
Effect of  Rat Aorta Culture-derived  Myofibroblasts 
on Angiogenesis 
To investigate if the angiogenic response of the rat aorta to 
TSP was mediated by accessory nonendothelial cells which 
were sensitive to TSP stimulation, aortic explants were cul- 
tured under serum-free conditions in collagen gels contain- 
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Figure 9. Effect of TSP on proliferation of bovine aortic endothelial 
cells  (BAE) and  rat aorta culture-derived  myofibroblasts (MF). 
Cells were cultured in serum-free medium and their number was 
determined  at daily intervals by the MTT cell proliferation  assay. 
TSP stimulated the proliferation of myofibroblasts but had no effect 
on BAE cells. Each data point is the mean of 3 cultures. Error bars 
represent  the SD. 
ing  increasing  concentrations  of exogenously added  myo- 
fibroblasts. Myofibroblasts stimulated angiogenesis by 100- 
115 % as compared to controls containing no exogenous cells 
(Fig.  13).  An even greater stimulation (167 %) was obtained 
with  myofibroblast cell  clones.  In  addition,  microvessels 
formed in the myofibroblast-containing gels were more sta- 
ble  and  survived longer than  control  microvessels,  which 
tended to regress at a faster rate. The angiogenic stimulation 
by myofibroblasts was dose-dependent with maximum effect 
obtained  at  50,000  cells/ml  of collagen.  Therefore,  myo- 
fibroblasts can directly promote angiogenesis. To determine 
whether the  angiogenic activity of the  myofibroblasts was 
mediated by soluble factor(s), we evaluated the effect of myo- 
fibroblast-conditioned medium on angiogenesis.  After 7 d, 
collagen gel cultures of rat aorta treated with myofibroblast- 
conditioned medium showed a  105%  stimulation of angio- 
genesis as compared to untreated controls.  Taken together 
these results suggest that matrix-bound TSP promotes angio- 
genesis indirectly  by stimulating the proliferation of myo- 
fibroblasts, which in turn  secrete angiogenic factor(s). 
Partial Characterization of Rat Aorta Culture-derived 
Myofibroblast Conditioned Medium 
The stimulatory activity of medium conditioned by myofi- 
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Figure 10. Effect of bFGF (10 ng/ml) on the proliferation of RAE 
cells  cultured  on collagen-TSP substrate  in serum-free  medium. 
bFGF promoted a threefold increase in the number of RAE cells 
on day 4 (p =  0.0007). RAE cells cultured on collagen-TSP in the 
absence of bFGF were unable to grow. 
broblasts isolated from the aortic cultures was retained by a 
heparin-agarose affinity chromatography column (Fig.  14) 
and was destroyed by proteolysis with trypsin. The activity 
was due to a protein >30 kD since the flow-through fractions 
of l0 kD and 30 kD Amicon filters were ineffective whereas 
fractions of larger molecular weight retained partial activity. 
Figure 11. Light micrograph of myofibroblast cell culture immuno- 
stained by the ABC method for alpha-smooth muscle actin.  Note 
the  positive  staining  of the  actin  cytoskeleton.  Magnification: 
x470. 
Nicosia and Tuszynski Thrombospondin Promotes Angiogenesis In Vitro  189 Figure  12.  Electron  micro- 
graph  of  cultured  myofibro- 
blasts. Note the abundant pe- 
ripheral  microfilaments  (*) 
and  pinocytotic vesicles (ar- 
row and inset). Magnification: 
×19,200;  inset,  ×43,000. 
Discussion 
The experiments  presented in this  study provide evidence 
that TSP incorporated in a fibrin or collagen  gel promotes 
angiogenesis  from  explants  of rat  aorta.  TSP appears  to 
stimulate angiogenesis indirectly through its growth-promoting 
effect on myofibroblasts  derived from the aortic wall.  TSP 
promoted the growth of fibroblast-like  cells from the aortic 
explants  before any microvessels  had developed.  Some of 
these cells stained for alpha-smooth muscle actin and, when 
isolated,  showed morphological  features of myofibroblasts. 
Consistent with the observations that expression of TSP is 
enhanced  by fibroblasts  and smooth muscle  cell  mitogens 
(10,  12),  that antibodies  against TSP  inhibit growth of rat 
aortic smooth muscle ceils (14), and that TSP stimulates the 
growth of fibroblasts  (27),  we  find that TSP promotes the 
growth  of myofibroblasts isolated  from rat aortic cultures. 
These  cells  in  turn  stimulate  angiogenesis  by  secreting 
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Figure 13. Effect of myofibro- 
blasts (left) and myofibroblast- 
conditioned  medium  (right) 
on rat aortic angiogenesis in 
collagen gel culture. Myofibro- 
blasts (MF) stimulated anglo- 
genesis by 115 % as compared 
to the control (C) containing 
no exogenous cells (day 13, p 
=  0.015; N  =  3).  Myofihro- 
blast-conditioned medium (M/z 
CM)  stimulated  the  anglo- 
genie response by 105 % (day 
7, p  =  0.007; N  =  5).  Error 
bars indicate SEM. 
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Figure 14.  Maximum number of microvessels formed in control 
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n=3. 
growth  factor(s)  as  previously described  (32,  33).  Myo- 
fibroblasts may promote angiogenesis also by producing ex- 
tracellular  matrix  molecules  required  by  the  endothelial 
cells (32). 
Our data also indicate that matrix-bound TSP acts as a per- 
missive substrate allowing endothelial cells to proliferate in 
response to growth factors such as bFGF. This is in contrast 
to soluble TSP,  which has anti-proliferative effects on en- 
dothelial cells (3, 8, 38). In fact, RAE cells cultured on a col- 
lagen matrix containing TSP increased threefold after 4 d of 
treatment with bFGE The same cells were unable to respond 
to bFGF when grown on uncoated plastic in the presence of 
soluble TSP,  as previously reported (3).  These results are 
consistent with the data of Morandi et al. (17) who showed 
that endothelial cells in culture require TSP as an attachment 
factor. 
The growth-promoting effects of TSP do not appear to be 
due to growth factor contaminants since anti-TSP adsorbed 
preparations had no effect on angiogenesis. In addition, the 
fact that our TSP had no effect on endothelial cell prolifera- 
tion rules out contamination by angiogenic cytokines such as 
bFGF,  which  directly  stimulate  endothelial  cell  growth. 
Moreover, bFGF is already present in the system as an en- 
dogenous component released by injured aortic endothelial 
and smooth muscle cells (46). It is also unlikely that the TSP 
effect was due to contamination with transforming growth 
factor beta-1  since this cytokine has anti-proliferative and 
anti-migratory effects on endothelial cells in vitro (51) and 
inhibits rat aortic angiogenesis when added to the collagen 
gel in its active form (unpublished observations). The angio- 
genic effect of TSP may be due in part to the capacity of this 
molecule to stimulate endothelial motility (38) and to modu- 
late endothelial cell adhesion  (21).  In  fact,  elongation of 
microvessels,  such  as  the  one  induced  by  TSP,  can  be 
promoted by a proliferation-independent migratory recruit- 
ment of endothelial cells (24). 
TSP stimulated growth at concentrations similar to those 
of TSP present in serum or fibrin after blood coagulation. 
We have observed that tissue culture growth medium sup- 
plemented with 5 % FBS contains 60 #g/ml of TSP as deter- 
mined by indirect immunoadsorbent assay using anti-human 
TSP antibody and human TSP as a standard. Therefore, the 
similarity in our cultures of the effect of TSP with that of se- 
rum suggests that TSP may be one of the growth components 
of serum. 
The previous report that TSP inhibits the angiogenic effect 
of bFGF in the rabbit cornea model is not inconsistent with 
our results (7). The rabbit cornea model depends on the ca- 
pacity  of molecules  to  diffuse  from  polymeric  implants 
placed in the cornea, which is avascular, toward the limbus, 
which is richly vascularized. TSP diffuses poorly even when 
placed into a  well of an agarose gel used for double im- 
munodiffusion (unpublished observations). Therefore, it is 
not surprising that TSE which has been shown to bind bFGF 
(39), does not promote angiogenesis in the cornea model but 
rather acts as a sink to sequester soluble angiogenic factors, 
impeding their diffusion toward their target vessels in the 
limbus. In our system the TSP effect on angiogenesis does 
not depend on diffusion since TSP is incorporated in the 
same matrix that contains the endothelial cells and the angio- 
genic factors, including bFGF (46), which are released by 
the aorta. 
Our  observation  that  TSP  promotes  angiogenesis  in- 
directly by promoting  the  proliferation of myofibroblasts 
which in turn stimulate angiogenesis is intriguing since these 
cells  may  have  derived  from  fibroblasts,  smooth  muscle 
cells, or pericytes (1, 5).  The possible origin of myofibro- 
blasts from fibroblasts is supported by the observation that 
fibroblasts can express alpha-smooth muscle actin (5) and 
stimulate angiogenesis in vitro (manuscript in preparation). 
Conversely, smooth muscle cells and pericytes have been 
shown to inhibit endothelial migration and proliferation (26, 
51).  However these cells,  which  are potential  sources of 
myofibroblasts, may modulate their activity depending on 
their state of differentiation since they require physical con- 
tact to inhibit the endothelium (26, 51). Thus, angiogenesis 
may be promoted when pericytes and smooth muscle cells 
de-differentiate becoming myofibroblasts and inhibited when 
the same cells mature and establish contacts with the en- 
dothelium (35). Alternatively, as proposed by others (34), 
the  aortic  wall  may  contain  different  subpopulations  of 
smooth muscle cells some of which respond to TSP and 
stimulate  angiogenesis.  This  dynamic  interpretation  of 
smooth  muscle  cell  function  would  reconcile apparently 
conflicting reports that have attributed either angiogenic (2) 
or anti-angiogenic roles (26, 51) to these cells. It is also con- 
sistent with the observations that the progressive increase in 
the number of pericytes in aortic cultures (Nicosia, R.  E, 
Nicosia and Tuszynski Thrombospondin Promotes Angiogenesis In Vitro  191 and E. Bonanno. 1992. Lab. Invest. 66:22A) and in other an- 
giogenesis systems (36) is eventually followed by cessation 
of vascular  proliferation and maturation  of microvessels. 
Partial characterization of the myofibroblast  conditioned 
medium  suggests  that  the  angiogenic  activity  is  due  to 
heparin-binding protein(s) having a molecular weight in ex- 
cess of 30 kD. However, more studies are needed to further 
characterize  these  factor(s)  and  determine  their  relation 
to TSP. 
In summary,  our observations suggest that matrix-bound 
TSP may play an important role in stimulating  the response 
of vascular  connective tissue to injury at sites of fibrin and 
platelet deposition.  Our studies provide evidence that TSP 
may mediate the proliferative response of the aortic wall to 
injury  and the vascularization of the atherosclerotic plaque 
by recruiting  myofibroblasts  which in turn stimulate angio- 
genesis. These observations also suggest that TSP may pro- 
mote  angiogenesis  and  myofibroblast  proliferation  during 
wound healing. Preliminary studies sowing that TSP directly 
promotes  healing  of full  thickness  skin  wounds  in  a  pig 
model  support  this  interpretation  (unpublished  data).  Fi- 
nally, TSP may potentiate tumor cell metastasis not only by 
promoting the adhesion of tumor cells and their subsequent 
sequestration in the lungs as previously reported (40),  but 
also by  stimulating  angiogenesis.  Recent reports  from our 
laboratories (Tuszynski, G. P., V. L. Rothman,  M.  Papale, 
B.  Zangwill,  and  R.  E  Nicosia.  1992.  Mol.  Biol.  Cell. 
3:20a) and by others (28, 49) showing that malignant breast 
tumors, which are richly vascularized (47),  contain a high 
level of stromal-associated TSP, are consistent with the con- 
clusion that TSP promotes angiogenesis. 
The authors wish to thank Drs. Antonio Ottinetti  and Elena Bonanno for 
their assistance during the early stages of this work and Dr. Sergio Villaschi 
for helpful discussions. The authors gratefully acknowledge Vicki  Roth- 
man,  Marion  Smith,  and James Diven  for their  excellent  technical  as- 
sistance. 
This work was supported by Public Health Service grants HL43392 (R. F. 
Nicosia) and HL28149  (G.  Tuszynski), and a  grant from the Southeast 
Pennsylvania Chapter of the American Heart Association (G. Tuszynski). 
Received  for publication 1 December 1992 and in revised form 8 October 
1993. 
References 
1. Adler, K. B., R. B. Low, K. O. Leslie, J. Michell, and J. N. Evans. 1989. 
Contractile cells in normal and fibrotic lung. Lab.  Invest. 60:473-485. 
2.  Alpern-Elran,  H.,  N. Morog,  F.  Robert,  G. Hoover,  N. Kalant, and S. 
Brem.  1989. Angiogenic  activity of the  atheroselerotic  carotid  artery 
plaque. J.  Neurosurg.  70:942-945. 
3. Bagavandoss, P., and J. W. Wilks.  1990. Specific inhibition of endothelial 
cell proliferation  by thrombospondin.  Biochem.  Biophys.  Res.  Comm. 
170:867-872. 
4.  DePoli, P., T. Bacon-Baguley, S. Kendra-Franczak, S. T. Cederholm, and 
D. A. Walz.  1989. Thrombospondin interaction with plasminogen. Evi- 
dence for binding to a specific region of the kringle structure of plasmino- 
gen. Blood.  73:976-982. 
5.  Demouli~re,  A.,  L.  Rubbia-Brandt,  A.  Abdiu,  T.  Walz,  A.  Macieira- 
Coelbo, and G. Gabbiani. 1992. Alpha-smooth muscle actin is expressed 
in a subpopulation of cultured and cloned fibroblasts and is modulated by 
gamma-interferon.  Exp.  Cell Res.  201:64-73. 
6.  Elsdale, T., and J. Bard.  1972. Collagen substrata for studies on cell be- 
havior. J.  Cell Biol.  54:626-632. 
7. Good, D. J., P. J. Polverini, F. Rastinejad, M. M. LeBeau, R. S. Lemons, 
W. A. Frazier,  and N. P. Bouck.  1990. A tumor suppressor-dependent 
inhibitor of angiogenesis is immunologically and functionally indistin- 
guishable from a fragment of thrombospondin.  Proc.  Natl.  Acad.  Sci. 
USA.  87:6624-6628. 
8. Iruela-Arispe,  M. L., P. Bornstein, and H. Sage. 1990. Thrombospondin 
exerts an antiangiogenic effect on cord formation by endothelial cells in 
vitro.  Proc.  Natl.  Acad.  Sci.  USA.  88:5026-5030. 
9. Jaffe, E. A., J. T. Ruggiero, L. L. K. Leung, M. J. Doyle, P. J. McKeown- 
Longo, and D. F. Mosher.  1983. Cultured human fibroblasts synthesize 
and secrete thrombospondin and incorporate it into the extracellular ma- 
trix.  Proc.  Natl.  Acad.  Sci.  USA.  80:999-1002. 
10. Janat, M. F., and G. Liau.  1992. Transforming growth factor beta  1 is a 
powerful modulator of platelet-derived factor action in vascular smooth 
muscle cells. J.  Cell.  Physiol.  150:232-242. 
11.  Lawler, J.  1986. The structural and functional properties of thrombospon- 
din. Blood.  67:112-123. 
12.  Majack,  R.  A.,  S.  C.  Cook,  and  P.  Bornstein.  1985.  Platelet-derived 
growth  factor and  heparin-like  glycosaminoglycans regulate  thrombo- 
spondin synthesis and deposition in the matrix by smooth muscle cells. 
J.  Cell Biol.  101:1059-1071. 
13.  Majack, R. A., S. C. Cook, and P. Bornstein. 1986. Regulation of smooth 
muscle cell growth by components of the extracellular matrix: an auto- 
crine  role  for  thrombospondin.  Proc.  Natl.  Acad.  Sci.  USA.  83: 
9050-9054. 
14.  Majack,  R.  A.,  L.  V.  Goodman,  and V.  M.  Dixit.  1988. Cell  surface 
thrombospondin is functionally essential for vascular smooth muscle cell 
proliferation.  J.  Cell Biol.  106:415--422. 
15.  McPhearson, J., H. Sage, and P. Bornstein.  1981. Isolation and character- 
ization of a glycoprotein secreted by aortic endothelial cells in culture: 
apparent  identity  with platelet  thrombospondin.  J.  Biol.  Chem.  256: 
11330-11336. 
16.  Merrilees,  M.  J.,  and L.  Scott.  1981. Culture  of rat and pig aortic en- 
dothelial cells. Differences in their isolation, growth rate, and glycosami- 
noglycan synthesis. Atherosclerosis.  30:19-26. 
17. Morandi,  V.,  F.  Fauvel-Lafeve,  C.  Legrand,  and Y. J.  Legrand.  1993. 
Role of  thrombospondin in the adhesion of human endothelial cells in pri- 
mary culture.  In  Vitro Cell.  Dev.  Biol.  29A:585-591. 
18.  Mosmann, T.  1983. Rapid colorimetric assay for cellular growth and sur- 
vival. J.  lmmuno.  Methods.  65:55-63. 
19.  Mumby, S. M., G. J. Raugi, and P. Bornstein. 1984. Interactions ofthrom- 
bospondin with extracellular matrix proteins: selective binding to type V 
collagen. J.  Cell Biol.  98:646-652. 
20. Murphy-Ullrich,  J.  E., and D. F.  Mosher.  1985. Localization of throm- 
bospondin in clots formed in situ. Blood.  66:1098-1104. 
21.  Murphy-UUrich, J.  E., and M. Hook.  1989. Thrombospondin  modulates 
focal adhesions in endothelial cells. J.  Cell Biol.  109:1309-1319. 
22.  Nicosia, R. F., and J. A. Madri.  1987. The microvaseular extracellular ma- 
trix, developmental changes during angiogenesis in the aortic ring-plasma 
clot model. Am.  J.  Path.  128:78-90. 
23.  Nicosia, R. F., and A. Ottinetti.  1990. Growth of microvessels in serum- 
free matrix culture of rat aorta:  a quantitative assay of angiogenesis in 
vitro.  Lab.  Invest.  63:115-122. 
24. Nicosia,  R. F., E. Bonanno, and M.  Smith.  1993. Fibronectin promotes 
the elongation of microvessels during angiogenesis in vitro. J.  Cell Phys- 
iol.  154:654-661. 
25.  Nicosia,  R.  F.,  E.  Bonanno,  and  S.  Villaschi.  1992. Large-vessel  en- 
dothelium switches to a microvascular phenotype during angiogenesis in 
collagen gel culture of rat aorta. Atherosclerosis.  95:191-199. 
26.  Orlidge, A., and P. D'Amore.  1987. Inhibition of capillary endothelial cell 
growth by pericytes  and smooth muscle cells. J.  Cell Biol.  105:1455- 
1462. 
27.  Phan, S. H., R. G. Dillon, B. M. McGarry, and V. M. Dixit. 1989. Stimu- 
lation of fibroblast proliferation by thrombospondin.  Biochem. Biophys. 
Res.  Commun.  163:56-63. 
28.  Pratt, D. A., W. R. Miller, and J. Dawes. 1989. Thrombospondin in malig- 
nant and non-malignant breast  tissue.  Fur.  J.  Cancer &  Clin.  Oncol. 
25:343-350. 
29.  Raugi, G. J., S. M. Mumby,  D. Abbott-Brown, and P. Bornstein.  1982. 
Thrombospondin: synthesis and secretion by cells in culture. J. Cell Biol. 
95:351-354. 
30. Riser,  B.  L., J.  Varani,  K. O'Rourke,  and V.  M.  Dixit.  1988. Throm- 
bospondin binding by human squamous carcinoma and melanoma cells: 
relationship to biological activity. Exp.  Cell Res.  174:319-329. 
31.  Robey,  P.  G.,  M.  F.  Young,  L.  W.  Fisher,  and T.  D.  McClain.  1989. 
Thrombospondin is an osteoblast-derived component of mineralized ex- 
tracellular  matrix. J.  Cell Biol.  108:719-727. 
32.  Sato, N., Y. Sawasaki, A. Senoo, Y. Fuse, Y. Hirano, andT. Goto.  1987. 
Development of capillary networks from rat microvascular fragments in 
vitro: the role of myofibroblastic cells.  Microvasc.  Res.  33:194-210. 
33.  Satoh, T., M. Kan, K. Masuko,  and M. Obinata.  1989. Characterization 
of a new endothelial cell growth factor (f-ECGF) partially purified from 
the supernatant of  human fibroblast cells. Cell Struct. Funct. 14:731-740. 
34.  Schwartz, S., R. L. Heimark, and M. W. Majeski.  1990. Developmental 
mechanisms underlying  pathology of arteries.  Physiol.  Rev.  70:1177- 
1209. 
35. Sims, D. 1991. Recent advances in pericyte biology-implications  for health 
and disease.  Can.  J.  Cardiol.  7:431-443. 
36.  Switalska,  H.  I.,  S.  Niewiarowski,  G.  P.  Tuszynski,  B.  Rucinski,  A. 
Schmaier,  and  T.  A.  Morinelli.  1985. Radioimmunoassay  of human 
platelet thrombospondin: different patterns of b-thromboglobulin antigen 
The Journal of Cell Biology, Volume  124, 1994  192 secretion and clearance from the circulation. J.  Lab. Clin. Med. 106: 
690-700. 
37. Scott-Burden, T., T. J. Resink, U. Bauer, M. Burgin, and F. R. Buhler. 
1988.  Activation of S6 kinase in cultured vascular smooth muscle cells 
by  submitogenic levels  of thrombospondin.  Biochem. Biophys. Res. 
Commun.  150:278-286. 
38. Taraboletti, G., D. Roberts, L. A. Liotta, and R. Giavazzi. 1990. Platelet 
thrombospondin  modulates  endothelial  cell  adhesion,  motility,  and 
growth:  a  potential  angiogenesis regulatory factor. J.  Cell Biol. 111: 
765-772. 
39. Taraboletti, G., D. Belotti, and R. Giavazzi. 1992. Thrombospondin  modu- 
lates basic fibroblast growth factor activities on endothelial cells. Exs (Ex- 
per.  Suppl.).  61:210-213. 
40. Tuszynski, G, P., T. B. Gasic, V. L. Rothman, K. A. Knudsen, and G. J. 
Gasic. 1987. Thrombospondin potentiates tumor cell metastasis. Cancer 
Res. 47:4130--4141. 
41. Tuszynski, G. P., V. L. Rothman, A. Murphy, K. Siegler, andK. A. Knud- 
sen.  1988.  Thrombospondin promotes platelet aggregation. Blood.  72: 
109-115. 
42. Tuszynski, G. P., V. Rothman, A. Murphy, K. Siegler, L. Smith, S. Smith, 
J. Karczewski, and K. Knudsen. 1987. Thrombospondin promotes cell- 
substratum adhesion. Science  (Wash. DC).  236:1570-1573. 
43. Tuszynski, G. P., S. Srivastava, H. I. Switalska, J. C. Holt, C. S. Cier- 
niewski, and S. Niewiarowski.  1985. The interaction of human platelet 
thrombospondin with fibrinogen purification  and specificity  of interac- 
tion. J.  Biol. Chem. 260:12240-12245. 
44. Varani, J., B. J.  Nickoloff,  B. L. Riser, R. S. Mitra, K. O'Rourke, and 
V. M.  Dixit.  1988.  Thrombospondin-induced adhesion of human ker- 
atinocytes. J.  Clin. Invest.  81:1537-1544. 
45. Varani, J., B. L. Riser, L. A. Hughes, T. E. Carey, S. E. G. Fligiel, and 
V. M. Dixit. 1989. Characterization of thrombospondin synthesis, secre- 
tion and cell  surface expression by human tumor cells.  Clin.  & Exp. 
Metastasis.  7:265-276. 
46. Villaschi, S., and R. F. Nicosia. 1993. Angiogenic role of endogenous ba- 
sic fibroblast  growth factor released by rat aorta after injury. Am.  J. 
Pathol.  143:1-10. 
47. Weidner, N., J. P. Semple, W. R. Welch, and J. Folkman. 1991.  Tumor 
angioganesis and metastasis-correlation in invasive breast carcinoma. 
New Engl. J.  Med. 324(1):1-8. 
48. Wight, T. N., G. J. Raugi, S. M. Mumby, and P. Bornstein. 1985.  Light 
microscopic immunolocalization of thrombospondin in human tissues. J. 
Histochem.  Cytochem. 33:295-302. 
49. Wong, S. Y., A. T. Purdie, and P. Han. 1992. Thrombospondin and other 
possible related  matrix proteins in malignant and benign breast disease. 
Am. J.  Path. 140:1473-1482. 
50. Yabkowitz,  R., J. B. Lowe, and V. M. Dixit,  1989. Expression and initial 
characterization of a recombinant human thrombospondin heparin bind- 
ing domain. J.  Biol. Chem. 264:10888-10896. 
51. Yasufumi, S., and D. B. Rifkin. 1989. Inhibition of endothelial cell move- 
ment by pericytes and smooth muscle cells: activation of a latent trans- 
forming growth factor-betal-like molecule by plasmin during co-culture. 
J.  Cell Biol. 109:309-315. 
Nicosia and Tuszynski Thrombospondin Promotes Angiogenesis In  Vitro  193 